Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02389998 · ClinicalTrials.gov registry record · NA
Efficacy of Open Label Placebo in Children With FGIDs
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT02389998 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 31 participants.
The verdict
NCT02389998, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study is aimed at investigating the efficacy of placebo for symptom relief in children with abdominal pain related functional gastrointestinal disorders.
Interventions
- OTHER Placebo Suspension
- DRUG Hyoscyamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2014-07 |
| Est. Completion | 2019-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02389998
The ClinicalTrials.gov registry entry for NCT02389998 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Suspension is the first listed.
NCT02389998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02389998 about?
NCT02389998 is a clinical study titled "Efficacy of Open Label Placebo in Children With FGIDs". This study is aimed at investigating the efficacy of placebo for symptom relief in children with abdominal pain related functional gastrointestinal disorders.
What is the current status of trial NCT02389998?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2014-07. Estimated completion is 2019-07.
What interventions are being tested in trial NCT02389998?
The interventions under investigation include: Placebo Suspension (OTHER), Hyoscyamine (DRUG).
Who is sponsoring clinical trial NCT02389998?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.